25 XP   0   0   10

Biosergen AS
Buy, Hold or Sell?

Let's analyse Biosergen together

PenkeI guess you are interested in Biosergen AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biosergen AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biosergen AS

I send you an email if I find something interesting about Biosergen AS.

Quick analysis of Biosergen (30 sec.)










What can you expect buying and holding a share of Biosergen? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.18
Expected worth in 1 year
kr0.23
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
kr0.05
Return On Investment
4.3%

For what price can you sell your share?

Current Price per Share
kr1.17
Expected price per share
kr1.1 - kr1.41
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Biosergen (5 min.)




Live pricePrice per Share (EOD)

kr1.17

2. Growth of Biosergen (5 min.)




Is Biosergen growing?

Current yearPrevious yearGrowGrow %
How rich?$884.8k$1.7m-$721.2k-71.2%

How much money is Biosergen making?

Current yearPrevious yearGrowGrow %
Making money-$824.5k-$640.1k-$184.4k-22.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biosergen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#893 / 1072

Most Revenue
#920 / 1072

Most Profit
#225 / 1072

Most Efficient
#363 / 1072
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Biosergen? (5 min.)

Welcome investor! Biosergen's management wants to use your money to grow the business. In return you get a share of Biosergen.

What can you expect buying and holding a share of Biosergen?

First you should know what it really means to hold a share of Biosergen. And how you can make/lose money.

Speculation

The Price per Share of Biosergen is kr1.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosergen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosergen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.18. Based on the TTM, the Book Value Change Per Share is kr0.01 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosergen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.02-1.3%-0.02-1.4%-0.02-1.4%-0.02-1.4%-0.02-1.4%
Usd Book Value Change Per Share-0.02-1.4%0.000.1%-0.01-1.2%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-1.4%0.000.1%-0.01-1.2%0.000.1%0.000.1%
Usd Price Per Share0.10-0.15-0.57-0.36-0.36-
Price to Earnings Ratio-1.61--2.30--10.15--6.45--6.45-
Price-to-Total Gains Ratio-6.05--6.61--42.94--20.89--20.89-
Price to Book Ratio5.66--1.68-20.17-8.42-8.42-
Price-to-Total Gains Ratio-6.05--6.61--42.94--20.89--20.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.113373
Number of shares8820
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (8820 shares)10.8515.40
Gains per Year (8820 shares)43.4061.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10433306252
2087760123114
301301190185176
401741620246238
502172050308300
602602480370362
703042910431424
803473340493486
903913770554548
1004344200616610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.07.00.030.0%3.07.00.030.0%3.07.00.030.0%3.07.00.030.0%
Dividend per Share0.00.04.00.0%0.00.010.00.0%0.00.010.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share1.03.00.025.0%3.07.00.030.0%3.07.00.030.0%3.07.00.030.0%3.07.00.030.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Biosergen

About Biosergen AS

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of invasive fungal infections. The company was founded in 2004 and is based in Solna, Sweden.

Fundamental data was last updated by Penke on 2023-11-19 02:24:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Biosergen AS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biosergen earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biosergen AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.3%+168.3%
TTM--201.8%+201.8%
YOY--288.3%+288.3%
5Y--475.5%+475.5%
10Y--632.1%+632.1%
1.1.2. Return on Assets

Shows how efficient Biosergen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • -46.3% Return on Assets means that Biosergen generated kr-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biosergen AS:

  • The MRQ is -46.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -49.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.3%TTM-49.3%+3.0%
TTM-49.3%YOY-31.3%-18.0%
TTM-49.3%5Y-337.1%+287.8%
5Y-337.1%10Y-337.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.3%-12.4%-33.9%
TTM-49.3%-11.8%-37.5%
YOY-31.3%-11.0%-20.3%
5Y-337.1%-13.6%-323.5%
10Y-337.1%-15.1%-322.0%
1.1.3. Return on Equity

Shows how efficient Biosergen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • -87.9% Return on Equity means Biosergen generated kr-0.88 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biosergen AS:

  • The MRQ is -87.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -36.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-87.9%TTM-36.2%-51.7%
TTM-36.2%YOY-52.7%+16.4%
TTM-36.2%5Y-3,361.0%+3,324.8%
5Y-3,361.0%10Y-3,361.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-87.9%-14.9%-73.0%
TTM-36.2%-15.0%-21.2%
YOY-52.7%-13.2%-39.5%
5Y-3,361.0%-18.7%-3,342.3%
10Y-3,361.0%-19.5%-3,341.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Biosergen AS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosergen is operating .

  • Measures how much profit Biosergen makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biosergen AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY78.9%-78.9%
TTM-5Y31.5%-31.5%
5Y31.5%10Y31.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--288.2%+288.2%
TTM--293.7%+293.7%
YOY78.9%-304.1%+383.0%
5Y31.5%-455.8%+487.3%
10Y31.5%-568.9%+600.4%
1.2.2. Operating Ratio

Measures how efficient Biosergen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Biosergen AS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.478-0.478
TTM-5Y0.191-0.191
5Y0.19110Y0.1910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.948-2.948
TTM-3.225-3.225
YOY0.4783.885-3.407
5Y0.1915.988-5.797
10Y0.1917.846-7.655
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Biosergen AS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosergen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.11 means the company has kr2.11 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Biosergen AS:

  • The MRQ is 2.110. The company is able to pay all its short-term debts. +1
  • The TTM is 2.275. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.110TTM2.275-0.165
TTM2.275YOY3.410-1.135
TTM2.2755Y2.937-0.662
5Y2.93710Y2.9370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1104.061-1.951
TTM2.2754.483-2.208
YOY3.4105.670-2.260
5Y2.9376.256-3.319
10Y2.9376.629-3.692
1.3.2. Quick Ratio

Measures if Biosergen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Quick Ratio of 2.11 means the company can pay off kr2.11 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biosergen AS:

  • The MRQ is 2.110. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.174. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.110TTM2.174-0.064
TTM2.174YOY2.798-0.624
TTM2.1745Y2.669-0.495
5Y2.66910Y2.6690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1103.653-1.543
TTM2.1744.161-1.987
YOY2.7985.503-2.705
5Y2.6696.035-3.366
10Y2.6696.369-3.700
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Biosergen AS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosergen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosergen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that Biosergen assets are financed with 47.4% credit (debt) and the remaining percentage (100% - 47.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biosergen AS:

  • The MRQ is 0.474. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.676. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.676-0.202
TTM0.676YOY0.320+0.355
TTM0.6765Y0.505+0.170
5Y0.50510Y0.5050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4740.330+0.144
TTM0.6760.326+0.350
YOY0.3200.260+0.060
5Y0.5050.371+0.134
10Y0.5050.387+0.118
1.4.2. Debt to Equity Ratio

Measures if Biosergen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosergen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 90.1% means that company has kr0.90 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biosergen AS:

  • The MRQ is 0.901. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.455. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.901TTM0.455+0.446
TTM0.455YOY0.529-0.075
TTM0.4555Y1.413-0.958
5Y1.41310Y1.4130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9010.377+0.524
TTM0.4550.388+0.067
YOY0.5290.306+0.223
5Y1.4130.432+0.981
10Y1.4130.469+0.944
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Biosergen AS

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biosergen generates.

  • Above 15 is considered overpriced but always compare Biosergen to the Biotechnology industry mean.
  • A PE ratio of -1.61 means the investor is paying kr-1.61 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biosergen AS:

  • The EOD is -1.846. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.609. Based on the earnings, the company is expensive. -2
  • The TTM is -2.303. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.846MRQ-1.609-0.237
MRQ-1.609TTM-2.303+0.693
TTM-2.303YOY-10.149+7.847
TTM-2.3035Y-6.455+4.152
5Y-6.45510Y-6.4550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.846-1.847+0.001
MRQ-1.609-2.497+0.888
TTM-2.303-2.736+0.433
YOY-10.149-4.719-5.430
5Y-6.455-6.398-0.057
10Y-6.455-6.639+0.184
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biosergen AS:

  • The EOD is -2.217. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.933. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.387. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-2.217MRQ-1.933-0.284
MRQ-1.933TTM1.387-3.319
TTM1.387YOY-12.751+14.138
TTM1.3875Y-5.274+6.661
5Y-5.27410Y-5.2740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.217-2.053-0.164
MRQ-1.933-2.722+0.789
TTM1.387-3.420+4.807
YOY-12.751-6.608-6.143
5Y-5.274-8.240+2.966
10Y-5.274-8.875+3.601
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosergen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.66 means the investor is paying kr5.66 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Biosergen AS:

  • The EOD is 6.494. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.661. Based on the equity, the company is overpriced. -1
  • The TTM is -1.683. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.494MRQ5.661+0.833
MRQ5.661TTM-1.683+7.345
TTM-1.683YOY20.172-21.855
TTM-1.6835Y8.416-10.099
5Y8.41610Y8.4160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.4941.648+4.846
MRQ5.6611.901+3.760
TTM-1.6832.114-3.797
YOY20.1723.217+16.955
5Y8.4163.614+4.802
10Y8.4164.101+4.315
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biosergen AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1690.013-1428%-0.147-13%0.018-1036%0.018-1036%
Book Value Per Share--0.1800.206-13%0.353-49%0.295-39%0.295-39%
Current Ratio--2.1102.275-7%3.410-38%2.937-28%2.937-28%
Debt To Asset Ratio--0.4740.676-30%0.320+48%0.505-6%0.505-6%
Debt To Equity Ratio--0.9010.455+98%0.529+70%1.413-36%1.413-36%
Dividend Per Share----0%-0%-0%-0%
Eps---0.158-0.168+6%-0.171+8%-0.165+4%-0.165+4%
Free Cash Flow Per Share---0.132-0.161+22%-0.173+31%-0.171+29%-0.171+29%
Free Cash Flow To Equity Per Share---0.1320.022-711%-0.174+32%0.018-831%0.018-831%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap59302503.000+13%51699618.00077346683.400-33%298413236.250-83%187309743.450-72%187309743.450-72%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%0.789-100%0.315-100%0.315-100%
Operating Ratio----0%0.478-100%0.191-100%0.191-100%
Pb Ratio6.494+13%5.661-1.683+130%20.172-72%8.416-33%8.416-33%
Pe Ratio-1.846-15%-1.609-2.303+43%-10.149+531%-6.455+301%-6.455+301%
Price Per Share1.170+13%1.0201.526-33%5.888-83%3.696-72%3.696-72%
Price To Free Cash Flow Ratio-2.217-15%-1.9331.387-239%-12.751+560%-5.274+173%-5.274+173%
Price To Total Gains Ratio-6.941-15%-6.051-6.609+9%-42.938+610%-20.887+245%-20.887+245%
Quick Ratio--2.1102.174-3%2.798-25%2.669-21%2.669-21%
Return On Assets---0.463-0.493+7%-0.313-32%-3.371+629%-3.371+629%
Return On Equity---0.879-0.362-59%-0.527-40%-33.610+3722%-33.610+3722%
Total Gains Per Share---0.1690.013-1428%-0.147-13%0.018-1036%0.018-1036%
Usd Book Value--884890.8001013404.425-13%1734606.900-49%1451019.360-39%1451019.360-39%
Usd Book Value Change Per Share---0.0160.001-1428%-0.014-13%0.002-1036%0.002-1036%
Usd Book Value Per Share--0.0170.020-13%0.034-49%0.029-39%0.029-39%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.015-0.016+6%-0.017+8%-0.016+4%-0.016+4%
Usd Free Cash Flow---647970.300-793053.825+22%-847342.050+31%-837516.390+29%-837516.390+29%
Usd Free Cash Flow Per Share---0.013-0.016+22%-0.017+31%-0.017+29%-0.017+29%
Usd Free Cash Flow To Equity Per Share---0.0130.002-711%-0.017+32%0.002-831%0.002-831%
Usd Market Cap5746412.541+13%5009692.9847494893.621-33%28916242.593-83%18150314.140-72%18150314.140-72%
Usd Price Per Share0.113+13%0.0990.148-33%0.570-83%0.358-72%0.358-72%
Usd Profit---778203.900-824570.550+6%-640121.400-18%-788010.180+1%-788010.180+1%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.0160.001-1428%-0.014-13%0.002-1036%0.002-1036%
 EOD+5 -3MRQTTM+11 -18YOY+11 -205Y+14 -1710Y+14 -17

3.2. Fundamental Score

Let's check the fundamental score of Biosergen AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.846
Price to Book Ratio (EOD)Between0-16.494
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.110
Current Ratio (MRQ)Greater than12.110
Debt to Asset Ratio (MRQ)Less than10.474
Debt to Equity Ratio (MRQ)Less than10.901
Return on Equity (MRQ)Greater than0.15-0.879
Return on Assets (MRQ)Greater than0.05-0.463
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Biosergen AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.160
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets17,360
Total Liabilities8,228
Total Stockholder Equity9,132
 As reported
Total Liabilities 8,228
Total Stockholder Equity+ 9,132
Total Assets = 17,360

Assets

Total Assets17,360
Total Current Assets17,360
Long-term Assets17,360
Total Current Assets
Cash And Cash Equivalents 10,101
Net Receivables 7,259
Total Current Assets  (as reported)17,360
Total Current Assets  (calculated)17,360
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,228
Long-term Liabilities0
Total Stockholder Equity9,132
Total Current Liabilities
Total Current Liabilities  (as reported)8,228
Total Current Liabilities  (calculated)0
+/- 8,228
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)9,132
Total Stockholder Equity (calculated)0
+/- 9,132
Other
Cash and Short Term Investments 10,101
Common Stock Shares Outstanding 42,428
Liabilities and Stockholders Equity 17,360
Net Debt -10,101
Net Working Capital 9,132



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
> Total Assets 
275
43,213
40,244
29,486
18,458
13,617
12,934
33,790
25,385
17,360
17,36025,38533,79012,93413,61718,45829,48640,24443,213275
   > Total Current Assets 
275
43,213
40,244
32,649
18,458
13,617
12,934
33,790
25,385
17,360
17,36025,38533,79012,93413,61718,45832,64940,24443,213275
       Cash And Cash Equivalents 
0
41,277
36,838
21,665
9,702
5,720
9,456
29,342
16,788
10,101
10,10116,78829,3429,4565,7209,70221,66536,83841,2770
       Net Receivables 
1,670
1,670
25
6,337
8,756
7,897
3,478
0
8,597
7,259
7,2598,59703,4787,8978,7566,337251,6701,670
   > Long-term Assets 0000000000
> Total Liabilities 
250
6,931
10,329
9,253
3,560
7,059
20,703
10,996
7,709
8,228
8,2287,70910,99620,7037,0593,5609,25310,3296,931250
   > Total Current Liabilities 
6,563
6,563
10,329
12,415
3,560
7,059
20,703
10,997
7,709
8,228
8,2287,70910,99720,7037,0593,56012,41510,3296,5636,563
       Short-term Debt 
0
0
3,018
0
0
0
0
0
0
0
00000003,01800
       Short Long Term Debt 
0
0
3,018
0
0
0
0
0
0
0
00000003,01800
       Accounts payable 
6,563
6,563
4,326
9,909
3,560
7,059
20,703
6,811
0
0
006,81120,7037,0593,5609,9094,3266,5636,563
       Other Current Liabilities 
0
0
2,985
96
3,560
0
20,703
4,186
0
0
004,18620,70303,560962,98500
   > Long-term Liabilities 
0
368
0
-1
0
0
0
-1
0
0
00-1000-103680
> Total Stockholder Equity
25
36,282
29,915
20,233
14,898
6,558
-7,769
22,794
17,676
9,132
9,13217,67622,794-7,7696,55814,89820,23329,91536,28225
   Common Stock
702
702
702
702
14,898
6,558
-7,769
1,060
0
0
001,060-7,7696,55814,898702702702702
   Retained Earnings Total Equity0000000000
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
48,135
48,497
0
14,898
0
-7,769
21,734
0
0
0021,734-7,769014,898048,49748,1350



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-280
Gross Profit-280-280
 
Operating Income (+$)
Gross Profit-280
Operating Expense-33,848
Operating Income-34,129-34,128
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense33,8480
 
Net Interest Income (+$)
Interest Income135
Interest Expense-54
Other Finance Cost-0
Net Interest Income81
 
Pretax Income (+$)
Operating Income-34,129
Net Interest Income81
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-34,048-34,210
EBIT - interestExpense = -34,183
-34,048
-33,859
Interest Expense54
Earnings Before Interest and Taxes (EBIT)-34,129-33,994
Earnings Before Interest and Taxes (EBITDA)-33,994
 
After tax Income (+$)
Income Before Tax-34,048
Tax Provision-0
Net Income From Continuing Ops-34,048-34,048
Net Income-33,913
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses34,128
Total Other Income/Expenses Net81-81
 

Technical Analysis of Biosergen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosergen. The general trend of Biosergen is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosergen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biosergen AS.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.24 < 1.24 < 1.41.

The bearish price targets are: 1.14 > 1.14 > 1.1.

Tweet this
Biosergen AS Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biosergen AS. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biosergen AS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biosergen AS.

Biosergen AS Daily Moving Average Convergence/Divergence (MACD) ChartBiosergen AS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biosergen AS. The current adx is .

Biosergen AS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biosergen AS.

Biosergen AS Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biosergen AS.

Biosergen AS Daily Relative Strength Index (RSI) ChartBiosergen AS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biosergen AS.

Biosergen AS Daily Stochastic Oscillator ChartBiosergen AS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biosergen AS.

Biosergen AS Daily Commodity Channel Index (CCI) ChartBiosergen AS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biosergen AS.

Biosergen AS Daily Chande Momentum Oscillator (CMO) ChartBiosergen AS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biosergen AS.

Biosergen AS Daily Williams %R ChartBiosergen AS Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biosergen AS.

Biosergen AS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biosergen AS.

Biosergen AS Daily Average True Range (ATR) ChartBiosergen AS Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biosergen AS.

Biosergen AS Daily On-Balance Volume (OBV) ChartBiosergen AS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biosergen AS.

Biosergen AS Daily Money Flow Index (MFI) ChartBiosergen AS Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biosergen AS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-07-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-07-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-07-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-08-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-08-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-09-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-09-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-09-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-10-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Biosergen AS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biosergen AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.160
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biosergen with someone you think should read this too:
  • Are you bullish or bearish on Biosergen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosergen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biosergen AS

I send you an email if I find something interesting about Biosergen AS.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Biosergen AS.

Receive notifications about Biosergen AS in your mailbox!